WO1989008657A3 - Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques - Google Patents

Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques Download PDF

Info

Publication number
WO1989008657A3
WO1989008657A3 PCT/FR1989/000094 FR8900094W WO8908657A3 WO 1989008657 A3 WO1989008657 A3 WO 1989008657A3 FR 8900094 W FR8900094 W FR 8900094W WO 8908657 A3 WO8908657 A3 WO 8908657A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
compounds usable
ligand
nitruro
radio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1989/000094
Other languages
English (en)
Other versions
WO1989008657A2 (fr
Inventor
Roberto Pasqualini
Luciano Magon
Andre Bardy
Adriano Duatti
Andrea Marchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oris Industrie SA
Original Assignee
Oris Industrie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8803044A external-priority patent/FR2628428B1/fr
Priority claimed from FR8815414A external-priority patent/FR2639638B1/fr
Application filed by Oris Industrie SA filed Critical Oris Industrie SA
Priority to DE8989903166T priority Critical patent/DE68904905T2/de
Priority to JP1502987A priority patent/JPH07110869B2/ja
Priority to AT89903166T priority patent/ATE85619T1/de
Priority to US07/571,570 priority patent/US5300278A/en
Publication of WO1989008657A2 publication Critical patent/WO1989008657A2/fr
Publication of WO1989008657A3 publication Critical patent/WO1989008657A3/fr
Priority to SU904831069A priority patent/RU2026300C1/ru
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne la préparation de complexes de 99m-technetium ou 186-rhénium ou 188-rhénium, utilisables comme produits radiopharmaceutiques. Pour cette préparation, on fait réagir un composé oxygéné de 99mTc, 186Re ou 188Re, par exemple un pertechnétate ou un perrhénate d'ammonium ou de métal alcalin, avec un premier ligand choisi dans le groupe des phosphines et polyphosphines aliphatiques et aromatiques, substituées ou non, et un second ligand azoté constitué par un azoture d'ammonium ou de métal pharmaceutiquement acceptable ou par un composé azoté comportant un motif (alpha) tel que l'hydrazine, un dérivé d'hydrazine, l'acide dithiocarbazique et les dérivés d'acide dithiocarbazique. Le produit obtenu peut être utilisé tel quel comme produit radiopharmaceutique ou servir d'intermédiaire pour préparer d'autres produits radiopharmaceutiques par réaction d'échange avec un troisième ligand, un anticorps monoclonal ou un fragment d'anticorps.
PCT/FR1989/000094 1988-03-09 1989-03-08 Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques Ceased WO1989008657A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE8989903166T DE68904905T2 (de) 1988-03-09 1989-03-08 Herstellung von als radiopharmazeutische produkte verwendbare nitruroverbindungen.
JP1502987A JPH07110869B2 (ja) 1988-03-09 1989-03-08 放射性医薬品として使用できる９９ｍＴｃ、１８６Ｒｅまたは１８８Ｒｅの窒化物錯体の製造方法
AT89903166T ATE85619T1 (de) 1988-03-09 1989-03-08 Herstellung von als radiopharmazeutische produkte verwendbare nitruroverbindungen.
US07/571,570 US5300278A (en) 1988-03-09 1989-03-08 Process for the preparation of 99m Tc, 186 Re or 188 Re nitride complexes usable as radiopharmaceutical products
SU904831069A RU2026300C1 (ru) 1988-03-09 1990-09-07 Способ получения комплексов переходных металлов

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR88/03044 1988-03-09
FR8803044A FR2628428B1 (fr) 1988-03-09 1988-03-09 Procede de preparation de complexes de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques
FR88/15414 1988-11-25
FR8815414A FR2639638B1 (fr) 1988-11-25 1988-11-25 Procede de preparation de complexes de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques

Publications (2)

Publication Number Publication Date
WO1989008657A2 WO1989008657A2 (fr) 1989-09-21
WO1989008657A3 true WO1989008657A3 (fr) 1989-10-19

Family

ID=26226545

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1989/000094 Ceased WO1989008657A2 (fr) 1988-03-09 1989-03-08 Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques

Country Status (9)

Country Link
US (1) US5300278A (fr)
EP (1) EP0403524B1 (fr)
JP (1) JPH07110869B2 (fr)
AT (1) ATE85619T1 (fr)
AU (1) AU619538B2 (fr)
CA (1) CA1340899C (fr)
DE (1) DE68904905T2 (fr)
RU (1) RU2026300C1 (fr)
WO (1) WO1989008657A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664166A1 (fr) * 1990-07-04 1992-01-10 Cis Bio Int Procede de preparation de complexes nitruro de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques.
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
EP0710228B1 (fr) * 1993-07-19 1998-01-21 Resolution Pharmaceuticals Inc. Chelateurs de radionucleides de type hydrazino presentant une configuration n 3?s
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US5751629A (en) 1995-04-25 1998-05-12 Irori Remotely programmable matrices with memories
US6331273B1 (en) 1995-04-25 2001-12-18 Discovery Partners International Remotely programmable matrices with memories
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US5874214A (en) 1995-04-25 1999-02-23 Irori Remotely programmable matrices with memories
US6416714B1 (en) 1995-04-25 2002-07-09 Discovery Partners International, Inc. Remotely programmable matrices with memories
FR2736834B1 (fr) * 1995-07-17 1997-08-29 Cis Bio Int Produits radiopharmaceutiques a tropisme cardiaque comportant un complexe nitruro d'un metal de transition et ayant une clairance myocardique rapide
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
DE69721820T2 (de) 1996-12-18 2004-02-26 Nihon Medi-Physics Co. Ltd., Nishinomiya Nitrid-heterokomplexe von radioaktiven übergangsmetallen
US6403054B1 (en) * 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6570040B2 (en) 2000-03-16 2003-05-27 The Regents Of The University Of California Chemoselective ligation
DE60110127T2 (de) * 2000-05-12 2006-02-02 Wisconsin Alumni Research Foundation, Madison Ligationsverfahren und reagenzien zur bildung einer amid-bindung
US7256259B2 (en) * 2000-05-12 2007-08-14 Wisconsin Alumni Research Foundation Methods for ligation of molecules to surfaces
ES2315295T3 (es) * 2000-07-28 2009-04-01 Nihon Medi-Physics Co., Ltd. Radiofarmaco para obtencion de imagenes diagnosticas que contiene un heterocomplejo de nitruro de tecnecio-99m.
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
CA2489186C (fr) * 2002-06-07 2013-01-15 Wisconsin Alumni Research Foundation Synthese chimique de reactifs pour couplage peptidique
WO2006113695A1 (fr) * 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Polytherapie anticancereuse avec des composes bis(thiohydrazide) amide
JP5027144B2 (ja) 2006-01-20 2012-09-19 日本メジフィジックス株式会社 放射性画像診断のための窒化テクネチウム錯体の中間体化合物
TWI440632B (zh) 2006-08-21 2014-06-11 Synta Pharmaceuticals Corp 用於治療增生性疾病的化合物
JP2010502616A (ja) * 2006-08-31 2010-01-28 シンタ ファーマシューティカルズ コーポレーション 癌を治療するためのビス（チオヒドラジドアミド）の組み合わせ
RU2366434C1 (ru) * 2007-12-07 2009-09-10 Институт неорганической химии им. А.В. Николаева Сибирского отделения Российской Академии наук Гексаядерные кластерные комплексы рения на основе радиоактивных изотопов, обладающие противоопухолевыми свойствами

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003063A1 (fr) * 1983-12-29 1985-07-18 The Commonwealth Of Australia PREPARATION DE PRODUITS RADIOPHARMACEUTIQUES MARQUES AU 99mTc

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387087A (en) * 1980-04-18 1983-06-07 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4374821A (en) * 1982-06-28 1983-02-22 E. R. Squibb & Sons, Inc. Myocardial imaging agent and method
JPS59146971A (ja) * 1983-02-04 1984-08-23 株式会社　満尾総合研究所 複合体の製造法と製造装置
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003063A1 (fr) * 1983-12-29 1985-07-18 The Commonwealth Of Australia PREPARATION DE PRODUITS RADIOPHARMACEUTIQUES MARQUES AU 99mTc

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts, vol. 102, no. 24, 17 juin 1985 (Columbus, Ohio, US), U. Abram et al.: "Lipophilic techne-tium complexes. III. Chelate complexes of technetium(V) containing the technetium-nitrido core", voir page 694 *
Chemical Abstracts, vol. 95, no. 2, 13 juillet 1981 (Columbus, Ohio, US), L. Kaden et al.: "Nitrido complexes of technetium(V)", page 716 *

Also Published As

Publication number Publication date
EP0403524A1 (fr) 1990-12-27
AU3351889A (en) 1989-10-05
DE68904905D1 (de) 1993-03-25
ATE85619T1 (de) 1993-02-15
RU2026300C1 (ru) 1995-01-09
JPH07110869B2 (ja) 1995-11-29
JPH03504964A (ja) 1991-10-31
AU619538B2 (en) 1992-01-30
EP0403524B1 (fr) 1993-02-10
US5300278A (en) 1994-04-05
WO1989008657A2 (fr) 1989-09-21
CA1340899C (fr) 2000-02-15
DE68904905T2 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
WO1989008657A3 (fr) Preparation de complexes nitruro utilisables comme produits radiopharmaceutiques
WO1992000759A3 (fr) Complexes radiopharmaceutiques therapeutiques stabilises
UA32577C2 (uk) Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів
IE890169L (en) Diagnostic preparation
DK395484D0 (da) Bisamid-bisthiolforbindelser samt radiofarmaceutiske praeparater indeoldende disse
FI873509A7 (fi) Imidatsoliyhdisteet, menetelmä niiden valmistamiseksi ja näitä sisältävä farmaseuttinen seos.
IE59758B1 (en) Ether isonitriles and radiolabeled complexex thereof
AU651112B2 (en) Radiopharmaceutical formulations, their method of administration and process of preparation
FI841082A7 (fi) Yhteenliitetyt imidatsoliyhdisteet, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset seokset.
CA2037299A1 (fr) Antagonistes de la cck-a emetteurs de rayons gamma pour l'imagerie du pancreas
WO1992007860A3 (fr) COMPLEXES DE TECHNETIUM 99 m UTILISABLES COMME AGENTS RADIOPHARMACEUTIQUES
DE59408142D1 (de) Chelatbildner vom typ xn 1?s 1?o 1? für radioaktive isotope, deren metallkomplexe und ihre verwendung in diagnostik und therapie
IE791342L (en) Adduct of a k vitaminic compound
JPS57206686A (en) Pyrrolo(2,3-d)carbazole derivative and manufacture
KR960705842A (ko) N-알킬 펩티드 킬레이트 형성제, 방사핵종을 갖는 그의 금속 착물, 이들의 제조방법 및 이들 화합물을 함유한 방사성의약 조성물(n-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compound)
DE3063755D1 (en) Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation
NO842514L (no) Fremgangsmaate for fremstilling av bicyklo(3,2,1)oktankarboksylsyre-derivater.
GB1261060A (en) Phthalen-1-one derivatives
Mansur et al. Renal elimination of some 99mTc-labelled cysteamine derivatives
IT8319993A0 (it) Composizioni farmaceutiche contenenti composti a scheletro flavanonico, procedimento per lapreparazione di detti composti e nuovi composti ottenuti.
IL50983A (en) 5-alkylureido-1,3,4-thiadiazol-2-yl-sulphonyl-acetic-acid derivatives,process for the preparation of said compound and herbicidal compositions containing the same
GB1384684A (en) 1,3,5-triazine and process for the preparation thereof
NL7613607A (nl) Werkwijze ter bereiding van nieuwe (beta)-lactam verbindingen, alsmede deze verbindingen bevat- tende farmaceutische preparaten.
JPS5297983A (en) Preparation of alkylpyrazines
JPS5227768A (en) Preparation of 5-(beta-methylmercaptoethyl) -hydantoin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK JP NO SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK JP NO SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989903166

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989903166

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1989903166

Country of ref document: EP